Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3688-2 (MIR3688-2) is a human microRNA, a short (20–24 nucleotide) non-coding RNA involved in post-transcriptional regulation of gene expression. Like other microRNAs, it is transcribed as a primary transcript (pri-miRNA) by RNA polymerase II, processed into a precursor miRNA (pre-miRNA) by Drosha in the nucleus, and further processed by Dicer in the cytoplasm to generate the mature miRNA. The mature MIR3688-2 is loaded into the RNA-induced silencing complex (RISC), guiding it to target mRNAs, usually resulting in translational repression or mRNA destabilization. Specific biological functions, disease associations, or drug interactions for MIR3688-2 have not been described in the current literature[8][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3688-2 (MIR3688-2).